Laboratory diagnosis of pleural tuberculosis: An unsolved enigma

被引:0
作者
Mohapatra, Atish [1 ]
Gaikwad, Ujjwala [1 ]
Ganga, Ranganath T. [2 ]
Sharma, Pratibha [3 ]
机构
[1] All India Inst Med Sci, Dept Microbiol, Raipur, Chhattisgarh, India
[2] All India Inst Med Sci, Dept Pulm Med, Raipur, Chhattisgarh, India
[3] Shri Balaji Inst Med Sci, Dept Microbiol, Raipur, Chhattisgarh, India
关键词
Pleural tuberculosis; Adenosine deaminase; CBNAAT; Truenat; Mycobacterial culture; ADENOSINE-DEAMINASE;
D O I
10.1016/j.ijmmb.2025.100817
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pleural Tuberculosis (TB) diagnosis is challenging and the current diagnostic approach is multidisciplinary involving clinico-radiological methods in addition to laboratory parameters. The study aims to explore the role of all available parameters for pleural TB diagnosis. Methods: A cross-sectional study on suspected pleural TB patients was conducted at a tertiary care hospital in Chhattisgarh from February to November 2021. After obtaining consent and clinico-radiological information, pleural fluid was collected and tested for biochemical profile and detection of Mycobacterium tuberculosis using available microbiological parameters. Results: Out of 170 subjects, 26 had Definite TB (Microbiologically confirmed), 22 had Probable TB (clinicoradiologically confirmed), and 122 had No-TB. Necrotizing mediastinal lymphadenopathy, cervical lymphadenopathy & loculated effusion were significant radiological findings. Amongst biochemical parameters, (Receiver Operating Characteristic (ROC) cut off 40.0 U/L; AUC = 0.889) of Adenosine Deaminase (ADA) was proved to be a better biomarker than LDH (ROC cut off 442.0 IU/L; AUC = 0.645). Out of all available microbiological parameters, Cartridge Based Nucleic Acid Amplification Test (CBNAAT) performed better by identifying (6/7; 85.71 %) pleural TB cases when compared against Microbiological Reference Standards (MRS). While compared against Composite Reference Standards (CRS), Mycobacteria Growth Indicator Tube (MGIT) performed better than other microbiological parameters by identifying (19/48; 39.5 %), while both CBNAAT and Truenat could identify (6/16; 37.5 %) and (12/32; 37.5 %) respectively. Conclusion: In association with clinical and radiological features, ADA estimation is quite helpful in establishing or refuting the diagnosis of microbiologically negative pleural tuberculosis.
引用
收藏
页数:6
相关论文
共 16 条
  • [1] Akhtar S, 2022, J Clin Diagn Res, V16, pDC08
  • [2] [Anonymous], 2013, Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update, P19
  • [3] Tuberculous Pleural Effusion
    Cohen, Leah A.
    Light, Richard W.
    [J]. TURKISH THORACIC JOURNAL, 2015, 16 (01) : 1 - 9
  • [4] Increased pleural fluid adenosine deaminase in brucellosis is difficult to differentiate from tuberculosis
    Dikensoy, O
    Namiduru, M
    Hocaoglu, S
    Ikidag, B
    Filiz, A
    [J]. RESPIRATION, 2002, 69 (06) : 556 - 559
  • [5] High adenosine deaminase activity in the pleural effusion of a patient with Legionnaires' disease
    Dikensoy, Oner
    Fakili, Fusun
    Elbek, Osman
    Uysal, Nevin
    [J]. RESPIROLOGY, 2008, 13 (03) : 473 - 474
  • [6] Is Xpert MTB/RIF appropriate for diagnosing tuberculous pleurisy with pleural fluid samples? A systematic review
    Huo, Zhen-yu
    Peng, Li
    [J]. BMC INFECTIOUS DISEASES, 2018, 18
  • [7] Ko Y, 2017, TUBERC RESPIR DIS, V80, P35, DOI 10.4046/trd.2017.80.1.35
  • [8] Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
    Kohli, Mikashmi
    Schiller, Ian
    Dendukuri, Nandini
    Dheda, Keertan
    Denkinger, Claudia M.
    Schumacher, Samuel G.
    Steingart, Karen R.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2018, (08):
  • [9] Kurian T, 2021, J Adv Lung Health, P50
  • [10] The tuberculous pleural effusion
    Mcnally, Emma
    Ross, Clare
    Gleeson, Laura E.
    [J]. BREATHE, 2023, 19 (04)